| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 544.900.849 $ | +88.929.351 $ | 455.971.498 $ | +247.398.591 $ | 246.760.882 $ | +48.602.598 $ | 198.158.284 $ | +198.158.284 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 464.070.830 $ | +78.221.369 $ | 385.849.461 $ | +209.662.617 $ | 176.186.844 $ | +52.034.322 $ | 124.152.522 $ | +124.152.522 $ |
| Jazz Pharmaceuticals plc | JAZZ | 42.171.900 $ | +2.551.502 $ | 39.620.398 $ | +17.658.652 $ | 21.961.746 $ | +21.961.746 $ | ||
| Ascendis Pharma A/S | ASND | 6.591.767 $ | -24.465.520 $ | 31.057.287 $ | +31.057.287 $ | ||||
| Monopar Therapeutics | MNPR | 21.268.275 $ | +8.579.207 $ | 12.689.068 $ | +12.689.068 $ | ||||
| Centessa Pharmaceuticals plc | CNTA | 7.070.127 $ | -10.742.444 $ | 17.812.571 $ | +7.388.254 $ | 10.424.317 $ | +3.972.126 $ | 6.452.191 $ | +6.452.191 $ |
| MoonLake Immunotherapeutics | MLTX | 13.725.005 $ | +290.825 $ | 13.434.180 $ | +13.434.180 $ | ||||
| Syndax Pharmaceuticals Inc | SNDX | 4.687.660 $ | -8.104.465 $ | 12.792.125 $ | +12.792.125 $ | ||||
| Oculis Holding AG | OCS | 10.319.717 $ | +10.319.717 $ | ||||||
| ARGENX SE | ARGX | 5.669.298 $ | -2.535.135 $ | 8.204.433 $ | +8.204.433 $ | ||||
| NEUROCRINE BIOSCIENCES INC | NBIX | 7.312.770 $ | +7.312.770 $ | ||||||
| Silence Therapeutics plc | SLN | 201.475 $ | -1.864.071 $ | 2.065.546 $ | +2.065.546 $ | ||||
| 544.900.849 $ | +88.929.351 $ | 455.971.498 $ | +247.398.591 $ | 246.760.882 $ | +48.602.598 $ | 198.158.284 $ | +198.158.284 $ | ||
Erweiterte Einstellungen
×